Kaiser Permanente officials announced Tuesday that they are expanding COVID-19 vaccine trials to include children ages 5-11 in Oakland, Santa Clara and Sacramento.
The three trial sites on Monday began enrolling roughly 75 children in the 5-11 age range.
Kaiser’s Vaccine Study Center and Division of Research, both based in Oakland, are conducting the trial in concert with Pfizer and BioNTech, which co-developed the vaccine that will be used in the trial. The Pfizer vaccine is currently the only COVID-19 vaccine approved for minors.
Roughly 4,600 children are participating in trials across the country to determine the vaccine’s safety and efficacy in children under 12.
“There’s a lot of vigorous interest right now in terms of availability and there’s limited availability” for the study, said Vaccine Study Center director Dr. Nicky Klein.
Recommended for you
Kaiser’s Vaccine Study Center also participated in the clinical trials to determine the safety and efficacy of the Pfizer vaccine both in adults and children ages 12-17.
In the coming weeks, trials are also likely to open for children under age 5, Klein said, as logistics and finer details are still being worked out. Eventually, she said, medical experts intend to recommend that all children receive the vaccine once it is available to them.
On the trial’s current timeline, Klein said Pfizer could submit an emergency authorization for children 5-11 as early as September, provided the trial’s data shows the vaccine is as effective as it has been for other age groups.
“It may be around the start of school,” she said. “(That’s) probably the best-case scenario, but I think that’s still up in the air.”
This article was originally published by Pleasanton Weekly. CalMatters.org is a nonprofit, nonpartisan media venture explaining California policies and politics. Visit on Facebook or on Twitter @CalMatters
Keep the discussion civilized. Absolutely NO
personal attacks or insults directed toward writers, nor others who
make comments. Keep it clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. Don't threaten. Threats of harming another
person will not be tolerated. Be truthful. Don't knowingly lie about anyone
or anything. Be proactive. Use the 'Report' link on
each comment to let us know of abusive posts. PLEASE TURN OFF YOUR CAPS LOCK. Anyone violating these rules will be issued a
warning. After the warning, comment privileges can be
revoked.
Please purchase a Premium Subscription to continue reading.
To continue, please log in, or sign up for a new account.
We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.
A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!
(0) comments
Welcome to the discussion.
Log In
Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.